MRK vs GILD — Key Metrics
| Metric | MRK (MERCK & CO INC) | GILD (GILEAD SCIENCES INC) |
|---|---|---|
| Price | 145.31 | 149.05 |
| Market Cap | 358.5 Billion | 184.82 Billion |
| P/E (TTM) | 114.42 | -57.33 |
| P/B (Quarterly) | 7.565 | 13.717 |
| P/S (TTM) | 5.39 | 6.07 |
| Net Profit Margin (TTM) | 4.8 | -10.6 |
| Gross Margin (TTM) | 73.0 | 79.6 |
| ROE (TTM) | 6.6 | -16.3 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
MRK · MERCK & CO INC
Greatly Outperform
GILD · GILEAD SCIENCES INC
Outperform
Recommendation Summary
Stock MRK is projected to greatly outperform the market, stock GILD is projected to outperform the market. Upfront Recommendation: MRK.
Financial Metrics
Prices delayed ~15 min
| MRK | Metrics | GILD |
|---|---|---|
| $145.31 | Price | $149.05 |
| — | Market Capitalization | — |
| 5.39 | Price to Sales | 6.07 |
| 22.32 | Price to FCF Ratio | 14.28 |
| 7.38 | Price to Gross Profit | 7.62 |
| 11.77 | Price to R&D | 30.47 |
| 9.77 | Price to Current Assets | 13.25 |